We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Inpeco

Inpeco is a global leader in automation systems for clinical laboratories and designs cutting-edge solutions for both... read more Featured Products: More products

Download Mobile App





Inpeco Launches Next-Generation Total Lab Automation System

By LabMedica International staff writers
Posted on 01 Aug 2024
Print article
Image: The new FlexLab X total lab automation system unveiled at ADLM 2024 (Photo courtesy of Inpeco)
Image: The new FlexLab X total lab automation system unveiled at ADLM 2024 (Photo courtesy of Inpeco)

At ADLM 2024, Inpeco SA (Novazzano, Switzerland) is introducing FlexLab X, its new total lab automation system, to the global laboratory medicine community.

Set to redefine automation excellence, FlexLab X offers enhanced flexibility, a best-in-class user experience, and excellent performance. Open and flexible by design, FlexLab X allows labs to freely combine analyzers from different vendors, for optimal patient outcomes. Its standardized track components enable space-saving layouts tailored to a lab’s needs that scale easily in three dimensions, to support future growth. Offering sleek graphical user interfaces (GUI) and powerful Data Analytics functionalities, FlexLab X is intuitively easy to use and monitor. This simplifies daily work and helps eliminate errors, while KPI dashboards provide actionable insights to streamline workflows.

Thanks to its outstanding performance, FlexLab X assures rapid and consistent turnaround times (TAT) at all sample volume levels, and it supports premium-quality results that are fully traceable. Moreover, FlexLab X is designed to maximize uptime and reduce running costs, contributing to an attractive return on investment (ROI). Clinical laboratories benefit from safe and efficient workflows that get the daily routine done. Premium-quality results support improved patient outcomes, and the attractive return delivered by a FlexLab X investment helps labs to better cope with increasing budget pressures.

Related Links:
Inpeco SA

Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Mycoplasma Pneumoniae Virus Test
Mycoplasma Pneumoniae Virus Detection Kit
New
Toxoplasma Gondii Immunoassay
Toxo IgM AccuBind ELISA Kit

Print article

Channels

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Pathology

view channel
Image: Microscopic images showing healthy villi on the left and diseased villi on the right (Photo courtesy of Florian Jaeckle/University of Cambridge)

Powerful AI Tool Diagnoses Coeliac Disease from Biopsy Images with Over 97% Accuracy

Coeliac disease is an autoimmune disorder triggered by the consumption of gluten, causing symptoms such as stomach cramps, diarrhea, skin rashes, weight loss, fatigue, and anemia. Due to the wide variation... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.